These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 20014952
1. Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age. Kimberlin DW, Jacobs RF, Weller S, van der Walt JS, Heitman CK, Man CY, Bradley JS. Clin Infect Dis; 2010 Jan 15; 50(2):221-8. PubMed ID: 20014952 [Abstract] [Full Text] [Related]
2. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA, Absalón-Reyes JA, Novoa-Heckel G, de Lago A, Oliva I, Rodríguez Z, González-de la Parra M, Burke-Fraga V, Namur S. Clin Ther; 2007 Jun 15; 29(6):1146-52. PubMed ID: 17692728 [Abstract] [Full Text] [Related]
3. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir. Tyring SK, Baker D, Snowden W. J Infect Dis; 2002 Oct 15; 186 Suppl 1():S40-6. PubMed ID: 12353186 [Abstract] [Full Text] [Related]
4. An investigation of the steady-state pharmacokinetics of oral valacyclovir in immunocompromised children. Nadal D, Leverger G, Sokal EM, Floret D, Perel Y, Leibundgut K, Weller S. J Infect Dis; 2002 Oct 15; 186 Suppl 1():S123-30. PubMed ID: 12353197 [Abstract] [Full Text] [Related]
5. Comparative bioavailability of acyclovir from oral valacyclovir and acyclovir in patients treated for recurrent genital herpes simplex virus infection. Bras AP, Sitar DS, Aoki FY. Can J Clin Pharmacol; 2001 Oct 15; 8(4):207-11. PubMed ID: 11743593 [Abstract] [Full Text] [Related]
6. Pharmacokinetics of oral acyclovir in neonates and in infants: a population analysis. Tod M, Lokiec F, Bidault R, De Bony F, Petitjean O, Aujard Y. Antimicrob Agents Chemother; 2001 Jan 15; 45(1):150-7. PubMed ID: 11120958 [Abstract] [Full Text] [Related]
7. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy. Eisen D, Essell J, Broun ER, Sigmund D, DeVoe M. Bone Marrow Transplant; 2003 Jan 15; 31(1):51-5. PubMed ID: 12621507 [Abstract] [Full Text] [Related]
8. Multiple oral dosing of valacyclovir in horses and ponies. Garré B, Baert K, Nauwynck H, Deprez P, De Backer P, Croubels S. J Vet Pharmacol Ther; 2009 Jun 15; 32(3):207-12. PubMed ID: 19646083 [Abstract] [Full Text] [Related]
9. Vitreous penetration of orally administered valacyclovir. Huynh TH, Johnson MW, Comer GM, Fish DN. Am J Ophthalmol; 2008 Apr 15; 145(4):682-6. PubMed ID: 18226802 [Abstract] [Full Text] [Related]
10. Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older. Arora A, Mendoza N, Brantley J, Yates B, Dix L, Tyring S. J Infect Dis; 2008 May 01; 197(9):1289-95. PubMed ID: 18422441 [Abstract] [Full Text] [Related]
11. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA, Villalpando-Hernández J, Novoa-Heckel G, Oliva I, Cariño L, López-Bojórquez E, Burke-Fraga V, Namur S, González-de la Parra M. Clin Ther; 2009 Feb 01; 31(2):399-410. PubMed ID: 19302912 [Abstract] [Full Text] [Related]
12. Valacyclovir for the treatment of genital herpes. Brantley JS, Hicks L, Sra K, Tyring SK. Expert Rev Anti Infect Ther; 2006 Jun 01; 4(3):367-76. PubMed ID: 16771614 [Abstract] [Full Text] [Related]
13. Valacyclovir. New indication: for genital herpes, simpler administration. Can Fam Physician; 1999 Jul 01; 45():1698-700, 1703-5. PubMed ID: 10424269 [Abstract] [Full Text] [Related]
14. Pharmacokinetics and safety of valaciclovir in children with Epstein-Barr virus illness. Simon MW, Fish DN, Deeter RG. Drugs R D; 2002 Jul 01; 3(6):365-73. PubMed ID: 12516939 [Abstract] [Full Text] [Related]
15. Effects of valacyclovir in cats infected with feline herpesvirus 1. Nasisse MP, Dorman DC, Jamison KC, Weigler BJ, Hawkins EC, Stevens JB. Am J Vet Res; 1997 Oct 01; 58(10):1141-4. PubMed ID: 9328668 [Abstract] [Full Text] [Related]
16. Evaluation of orally administered valacyclovir in experimentally EHV1-infected ponies. Garré B, Gryspeerdt A, Croubels S, De Backer P, Nauwynck H. Vet Microbiol; 2009 Mar 30; 135(3-4):214-21. PubMed ID: 18986780 [Abstract] [Full Text] [Related]
17. A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation. Reischig T, Opatrny K, Bouda M, Treska V, Jindra P, Svecova M. Transpl Int; 2002 Dec 30; 15(12):615-22. PubMed ID: 12478408 [Abstract] [Full Text] [Related]
19. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients. Fife KH, Warren TJ, Justus SE, Heitman CK, HS2100275 STUDY TEAM. Sex Transm Dis; 2008 Jul 30; 35(7):668-73. PubMed ID: 18461016 [Abstract] [Full Text] [Related]
20. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV. Warren T, Harris J, Brennan CA. Clin Infect Dis; 2004 Nov 01; 39 Suppl 5():S258-66. PubMed ID: 15494897 [Abstract] [Full Text] [Related] Page: [Next] [New Search]